Literature DB >> 20021986

Treatment of chronic urticaria.

Ruzica Jurakić Toncić1, Jasna Lipozencić, Branka Marinović.   

Abstract

Urticaria is a disorder characterized by rapid onset of localized swelling of the skin or mucosa, called wheals or urtica. According to frequency and duration, urticaria can be divided into acute and chronic type. Chronic urticaria is any type of urticaria occurring every day or twice per week, lasting longer than 6 weeks. Chronic urticaria is a common disorder and estimated prevalence is 1% of the population. Also, it is not rare in childhood. The pathogenesis of chronic urticaria has not yet been completely understood. Chronic urticaria is a heterogeneous group of disorders, and according to the etiology and cause, several groups of chronic urticaria are distinguished, i.e. autoimmune, pseudoallergic, infection-related, physical urticaria, vasculitis urticaria and idiopathic urticaria. Treatment and management of chronic urticaria can be non-pharmacological and pharmacological, and sometimes it is not possible to control the disease with antihistamines only, which are considered to be the mainstay of treatment. In severe cases of chronic urticaria, especially if autoimmunity has been proven, several authors describe different modules of immunomodulation: cyclosporine, cyclophosphamide, mycophenolate-mofetil, omalizumab, plasmapheresis, systemic corticosteroids, and immunoglobulin therapy. This article primarily addresses the treatment of chronic idiopathic and autoimmune urticaria.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20021986

Source DB:  PubMed          Journal:  Acta Dermatovenerol Croat        ISSN: 1330-027X            Impact factor:   1.256


  3 in total

1.  Comparative Evaluation of the Therapeutic Efficacy and Safety of Injected Histaglobulin versus Autologous Serum Therapy in Chronic Urticaria.

Authors:  Sumir Kumar; Simranjeet Singh Dhillon; B K Brar; Amarbir Singh
Journal:  J Clin Aesthet Dermatol       Date:  2021-03-01

2.  Plasmapheresis: Is it a potential alternative treatment for chronic urticaria?

Authors:  Laima Aleksandraviciute; Laura Malinauskiene; Kestutis Cerniauskas; Anzelika Chomiciene
Journal:  Open Med (Wars)       Date:  2021-12-23

3.  Weekly injection of histaglobulin produces long-term remission in chronic urticaria: A prospective clinical study.

Authors:  Gurumoorthy Rajesh; Subramaniam Keerthi; Kaliaperumal Karthikeyan; Murugan Venkatesan
Journal:  Indian J Pharmacol       Date:  2016 May-Jun       Impact factor: 1.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.